Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Campaigns
Marketing
Novartis earns FDA ire for ‘misleading’ Fabhalta ad imagery
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
Andrea Park
Sep 30, 2025 11:12am
Biogen-backed web series gets Bill Nye back in the lab
Sep 30, 2025 9:45am
Guardant backs ALA's lung cancer testing awareness drive
Sep 25, 2025 9:45am
Vertex signs up NBA All-Star Jayson Tatum to promote Journavx
Sep 24, 2025 10:30am
Exact scares up Cologuard campaign starring Matthew Lillard
Sep 22, 2025 11:16am
Merck, St. Louis Cardinals pitch heart disease awareness push
Sep 17, 2025 4:58pm